The BIO Asia International Conference brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Eurocine Vaccines will be on site to meet with industry representatives, present our technology platform Endocine™ and the latest results from the clinical study conducted with first product candidate Immunose™ FLU.

More information about the conference can be found here: BIO Asia

Meetings with CEO Hans Arwidsson can be booked through the Partnering System: BIO Asia Partnering